Joan Carles Reverter

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Joan Carles Reverter, H. Kessels, Raman Kumar et al. · Journal of Clinical Investigation · 1996 · 398 citations · Full text

Medicine, Cardiology, Pharmacology +17

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · The Lancet Infectious Diseases · 2018 · 297 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy

Antonia Perelló, Juan Carlos García‐Pagán, Rosa Gilabert et al. · Hepatology · 2002 · 218 citations

Medicine, Internal Medicine, Surgery +17

Bone Marrow Changes in Anorexia Nervosa Are Correlated With the Amount of Weight Loss and Not With Other Clinical Findings

Eugènia Abella, Evarist Feliú, Isabel Granada et al. · American Journal of Clinical Pathology · 2002 · 205 citations · Full text

Medicine, Pathology, Psychiatry +17

Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension

Vincenzo La Mura, Joan Carles Reverter, A. Flores-Arroyo et al. · Gut · 2011 · 181 citations

Medicine, Surgery, Hemodynamic Management +16